ECMO Patients' platelet shifts could explain bleeding risks
NCT ID NCT07334457
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at how different types of platelets change in patients on ECMO, a machine that helps the heart and lungs. Researchers will track 75 adults in intensive care to see if shifts in platelet populations relate to bleeding or clotting problems. The goal is to better understand these complications, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better manage bleeding and clotting complications in ECMO patients.
- What could go wrong
- This is a small observational study, so it may not lead to immediate changes in treatment. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'anesthésie-réanimation - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Spinal cord zap may help people breathe again after neck injury
- Tweaking ventilator settings could ease breathlessness and cut PTSD risk in ICU survivors
- AI could predict the perfect moment to take ICU patients off ventilators
- Could a watchful software save ICU patients from organ failure?
- New anxiety program for ICU survivors shows promise in early trial